購読する
モデル製品
サービス
前臨床薬効評価
コミュ二ティー
huHSC-NKG-ProM Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
huHSC-NKG-ProM Mouse
製品名
huHSC-NKG-ProM Mouse
製品ID
C001544
系統名
huHSC-ProM-NOD.Cg-PrkdcscidIl2rgem1cya/Cya
背景情報
NKG
状況
このマウス系統を論文で使用する場合は、「huHSC-NKG-ProM Mouse（カタログ番号C001544）はサイアジェンから購入しました。」と引用してください。
Immunodeficient Mice
Humanized Immune System Models
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
Immunodeficient Mice
Humanized Immune System Models
基本情報
検証 Data
関連リソース
基本情報
遺伝子名
遺伝子別名
gc, p64, [g]c, CD132, gamma(c)
NCBI ID
染色体
Chr X
MGI ID
さらに
系統詳細
NKG mice (Catalog number: C001316) are severely immunodeficient mice generated by Cyagen through deleting the Il2rg gene from NOD-Scid mice. NKG mice exhibit deficiency of mature T cells, B cells, and functional NK cells, reduced complement activity, and weak phagocytosis of human-derived cells by macrophages, which are well suited for the transplantation of human hematopoietic stem cells (HSC), peripheral blood mononuclear cells (PBMC), adult stem cells and tissues, and patient-derived xenografts (PDX).
huHSC-NKG mice are immune system humanized mouse models constructed by transplanting human hematopoietic stem cells (HSC) into NKG mice after sub-lethal dose irradiation. This model has a long lifespan and can successfully reconstitute various immune cells. In addition, huHSC-NKG mice typically do not develop graft-versus-host disease (GvHD) and the reconstitution period can be long.
The huHSC-NKG-ProM mouse is the latest enhanced version of the huHSC-NKG series, where "Pro" indicates the enhanced series and "M" specifically refers to myeloid cells. This mouse utilizes advanced neonate technology and has been process-optimized to allow for the development of lymphoid T cells and B cells, as well as myeloid cells such as monocytes. It is suitable for research on immune checkpoint inhibitors and drugs that target myeloid cells.
適用分野
Tumor Immunology Research: Suitable for drug types such as immune checkpoint inhibitors and those with targets on myeloid cells, for example, combining a PD-1 monoclonal antibody with drugs that affect Macrophage polarization;
Autoimmune Disease Research: Evaluation of the pathogenesis of autoimmune diseases and potential therapeutic strategies;
Drug Metabolism and Toxicity Research: Assessment of the pharmacokinetic properties and toxic effects of candidate compounds in vivo.
検証 Data
1. Survival and Growth Curves
During the process of human immune system reconstitution, the body weight of NKG mice was maintained at 18-22 grams, and the survival rate at 18 weeks post-reconstitution was 85%.
Figure 1. Survival and body weight changes in NKG mice following human hematopoietic stem cells (HSCs) transplantation.
2. Reconstitution of Human Leukocytes in Peripheral Blood
Transplantation of human umbilical cord blood-derived hematopoietic stem cells (HSCs) into NKG mice for human immune system reconstitution resulted in a stable reconstitution efficacy, with the proportion of human-derived CD45+ leukocytes reaching approximately 40%-60%.
Figure 2. Reconstitution of human CD45+ leukocytes in the peripheral blood of NKG mice following transplantation of human HSCs.
3. Reconstitution of Human T Cells and B Cells in Peripheral Blood
The gradual reconstruction of T cells commenced from the 10th week post-transplantation of human hematopoietic stem cells (HSCs), with the mean T cell content reaching 40% by the 16th week. The proportion of B cells ranged from approximately 60-80% during weeks 6-8 post-reconstruction. Subsequently, as the T cell proportion increased, the B cell proportion gradually decreased to 40-60%.
Figure 3. Reconstitution of human T cells and B cells in the peripheral blood of NKG mice following transplantation of human HSCs.
4. Reconstitution of Human NK Cells and Monocytes in Peripheral Blood
The average reconstitution proportion of Natural Killer (NK) cells was below 5%, while monocytes in peripheral blood achieved a reconstitution proportion of 5-10%. Given that macrophages are primarily derived from monocytes, monocyte detection is therefore the main focus in peripheral blood samples.
Figure 4. Reconstitution of human NK cells and monocytes in the peripheral blood of NKG mice following transplantation of human HSCs.
関連リソース
お問い合わせ
ご不明な点やご質問などございましたら、お気軽にお問い合わせください。担当スタッフがサポートさせていただきます。下記のフォームにご記入いただければ、1〜2営業日以内に折り返しご連絡いたします。
Related Product
All Related Productsお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。